Abstracts

FAILURE TO ACHIEVE HCV MICROELIMINATION AMONG PLWH IN SPAIN

Spain is close to HCV microelimination, so rates of recently acquired HCV infection (RAHC) should decrease. Nowadays, men who have sex with men (MSM) carry the highest risk of HCV acquisition. Our aim was to estimate the incidence of and the factors associated with RAHC, together with reinfection rates, among patients infected with HIV through…

FREQUENT HBsAg CLEARANCE DURING TENOFOVIR THERAPY IN HIV/HBV COINFECTION

Among persons with hepatitis B virus (HBV)-monoinfection, loss of the hepatitis B surface antigen (HBsAg), also described as HBV functional cure, is a rare event but associated with reduced incidence of liver-related complications. We aimed to assess the proportion of HBV functional cure among persons with HIV/HBV-coinfection during long-term tenofovir-therapy who experienced HBV functional cure,…

EVALUATION OF COMBINATIONS OF CLINICAL INTEGRASE MUTATIONS ON InSTI RESISTANCE

While major integrase strand transfer inhibitor (INSTI) resistance mutations have been identified, the effect of mutation combinations on phenotypic resistance are less clear. We identified a clinical HIV sequence with four major integrase resistance mutations, and characterized in vitro INSTI phenotypic susceptibility of all combinations thereof to deconstruct their individual and combined effects. Routine clinical…

A MULTIPLEXED HIV DRUG RESISTANCE (DR) ASSAY TO SURVEY HIVDR MUTATIONS IN POL REGION

As the WHO universal treatment policy using dolutegravir (DTG) for HIV treatment approaches full implementation globally, a user friendly, sensitive, low-cost HIVDR assay to survey Integrase (INT) HIVDR is urgently needed. By incorporating newly designed INT primers into Thermo Fisher (TF) HIV-1 Genotyping Assay, we constructed a multiplexed assay to detect HIVDR mutations of Protease,…